HomeAI · summaries
Storia in 8 fonti
GLP-1 drugs may reduce the risk of cancer progressing, study suggests
Research from the Cleveland Clinic found that people who started a GLP-1 drug after their diagnosis were less likely to progress to stage 4.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
healio.com
GLP-1s demonstrate ‘large’ & ‘consistent’ protective effects against cancer metastases
CHICAGO — GLP-1 receptor agonists may help mitigate progression of at least some obesity-related cancers, according to retrospective study results presented at ASCO Annual…
- ·
medpagetoday.com
GLP-1s Linked to Lower Risk of Cancer Spread in Four Tumor Types
Accumulating evidence of possible benefit warrants randomized trials, experts say
